Lindbrook Capital, LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,414
+35.7%
378
+21.5%
0.00%
Q1 2023$1,042
-29.5%
311
+1.3%
0.00%
Q4 2022$1,477
-26.2%
307
+6.2%
0.00%
Q3 2022$2,0000.0%289
-7.7%
0.00%
Q2 2022$2,000313
+526.0%
0.00%
Q4 2021$0500.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$4,712,40033.11%
BML Capital Management, LLC 2,236,239$8,363,5347.52%
TANG CAPITAL MANAGEMENT LLC 3,026,455$11,318,9421.67%
Stonepine Capital Management, LLC 752,088$2,812,8091.02%
Bain Capital Life Sciences Investors, LLC 2,485,638$9,296,2860.96%
CM Management, LLC 250,000$9350.91%
EcoR1 Capital, LLC 6,995,861$26,164,5200.64%
Cormorant Asset Management, LP 1,547,181$5,786,4570.32%
SECTORAL ASSET MANAGEMENT INC 501,537$1,875,7480.31%
Auour Investments LLC 177,000$661,9800.28%
View complete list of ATEA PHARMACEUTICALS INC shareholders